propranolol has been researched along with Exanthema Subitum in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Exanthema Subitum: An acute, short-lived, viral disease of infants and young children characterized by a high fever at onset that drops to normal after 3-4 days and the concomitant appearance of a macular or maculopapular rash that appears first on the trunk and then spreads to other areas. It is the sixth of the classical exanthematous diseases and is caused by HHV-6; (HERPESVIRUS 6, HUMAN). (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The propranolol treatment for the patient with suspected of bronchial asthma was suspended for 4 months." | 5.48 | Oral propranolol for infantile hemangiomas beyond the proliferative phase. ( Kagami, S; Katori, T, 2018) |
| "The propranolol treatment for the patient with suspected of bronchial asthma was suspended for 4 months." | 1.48 | Oral propranolol for infantile hemangiomas beyond the proliferative phase. ( Kagami, S; Katori, T, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kagami, S | 1 |
| Katori, T | 1 |
1 other study available for propranolol and Exanthema Subitum
| Article | Year |
|---|---|
Oral propranolol for infantile hemangiomas beyond the proliferative phase.
Topics: Administration, Oral; Asthma; Exanthema Subitum; Female; Hemangioma; Humans; Infant; Male; Photograp | 2018 |